Theasinensin A attenuated diabetic development by restoring glucose homeostasis, improving hepatic steatosis and modulating gut microbiota in high-fat-diet/streptozotocin-induced diabetic mice

Food Science and Human Wellness - Tập 12 - Trang 2073-2086 - 2023
Weiqi Xu1, Yujie Huang1, Wangting Zhou1, Yujia Peng1, Xuhui Kan1, Wei Dong1, Guijie Chen1, Xiaoxiong Zeng1, Zhonghua Liu2,3
1College of Food Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China
2Key Laboratory of Ministry of Education for Tea Science, Hunan Agricultural University, Changsha 410128, China
3National Research Center of Engineering Technology for Utilization of Botanical Functional Ingredients, Changsha 410128, China

Tài liệu tham khảo

Saeedi, 2019, Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition, Diabetes Res. Clin. Pract., 157, 10.1016/j.diabres.2019.107843 DeFronzo, 2015, Type 2 diabetes mellitus, Nat. Rev. Dis. Primers, 1, 15019, 10.1038/nrdp.2015.19 Kietsiriroje, 2019, Double diabetes: a distinct high-risk group?, Diabetes Obes. Metab., 21, 2609, 10.1111/dom.13848 Roden, 2019, The integrative biology of type 2 diabetes, Nature, 576, 51, 10.1038/s41586-019-1797-8 Gribble, 2021, Metabolic messengers: glucagon-like peptide 1, Nat. Metab., 3, 142, 10.1038/s42255-020-00327-x Drucker, 2018, Mechanisms of action and therapeutic application of glucagon-like peptide-1, Cell Metab, 27, 740, 10.1016/j.cmet.2018.03.001 Abd El Aziz, 2017, A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients, Diabetes Obes. Metab., 19, 216, 10.1111/dom.12804 Rosenstock, 2020, Impact of a weekly glucagon-like peptide 1 receptor agonist, albiglutide, on glycemic control and on reducing prandial insulin use in type 2 diabetes inadequately controlled on multiple insulin therapy: a randomized trial, Diabetes Care, 43, 2509, 10.2337/dc19-2316 Desai, 2016, A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility, Cell, 167, 1339, 10.1016/j.cell.2016.10.043 Sonnenburg, 2016, Diet-microbiota interactions as moderators of human metabolism, Nature, 535, 56, 10.1038/nature18846 Fan, 2021, Gut microbiota in human metabolic health and disease, Nat. Rev. Microbiol., 19, 55, 10.1038/s41579-020-0433-9 Chevalier, 2015, Gut microbiota orchestrates energy homeostasis during Cold, Cell, 163, 1360, 10.1016/j.cell.2015.11.004 Lynch, 2016, The human intestinal microbiome in health and disease, N. Engl. J. Med, 375, 2369, 10.1056/NEJMra1600266 Allin, 2018, Aberrant intestinal microbiota in individuals with prediabetes, Diabetologia, 61, 810, 10.1007/s00125-018-4550-1 Zhong, 2019, Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics, Ebiomedicine, 47, 373, 10.1016/j.ebiom.2019.08.048 David, 2014, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820 Zhu, 2021, Liubao brick tea activates the PI3K-Akt signaling pathway to lower blood glucose, metabolic disorders and insulin resistance via altering the intestinal flora, Food Res. Int., 148, 10.1016/j.foodres.2021.110594 Chen, 2019, Green tea polyphenols modify the gut microbiome in db/db mice as co-abundance groups correlating with the blood glucose lowering effect, Mol. Nutr. Food Res., 63, 10.1002/mnfr.201801064 Nonaka, 1983, Tannins and related compounds. XV. a new class of dimeric flavan-3-ol gallates, theasinensins A and B, and proanthocyanidin gallates from green tea leaf, Chem. Pharm. Bull, 31, 3906, 10.1248/cpb.31.3906 Tanaka, 2002, Accumulation of epigallocatechin quinone dimers during tea fermentation and formation of theasinensins, J. Nat. Prod, 65, 1582, 10.1021/np020245k Tanaka, 2003, Production of theasinensins A and D, epigallocatechin gallate dimers of black tea, by oxidation-reduction dismutation of dehydrotheasinensin A, Tetrahedron, 59, 7939, 10.1016/j.tet.2003.08.025 Liu, 2021, Insights in the recalcitrance of theasinensin A to human gut microbial degradation, J. Agric. Food Chem, 69, 2477, 10.1021/acs.jafc.1c00727 Liu, 2021, Microbial metabolism of theaflavin-3,3'-digallate and its gut microbiota composition modulatory effects, J. Agric. Food Chem., 69, 232, 10.1021/acs.jafc.0c06622 Yang, 2020, Nanochemoprevention with therapeutic benefits: an updated review focused on epigallocatechin gallate delivery, Crit. Rev. Food Sci. Nutr., 60, 1243, 10.1080/10408398.2019.1565490 Weerawatanakorn, 2015, Chemistry and health beneficial effects of oolong tea and theasinensins, Food Sci. Human Wellness, 4, 133, 10.1016/j.fshw.2015.10.002 Miyata, 2013, Theflavins and theasinensin A derived from fermented tea have antihyperglycemic and hypotriacylglycerolemic effects in KK-Ay mice and Sprague-Dawley rats, J. Agric. Food Chem., 61, 9366, 10.1021/jf400123y Shii, 2011, Biomimetic one-pot preparation of a black tea polyphenol theasinensin A from epigallocatechin gallate by treatment with copper(II) chloride and ascorbic acid, Chem. Pharm. Bull., 59, 1183, 10.1248/cpb.59.1183 Tao, 2020, Preparation of theasinensin A and theasinensin B and exploration of their inhibitory mechanism on α-glucosidase, Food Funct, 11, 3527, 10.1039/C9FO03054A Lin, 2017, (−)-Epicatechin-3-O-β-D-allopyranoside from davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice, PLoS One, 12 Neschen, 2015, Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice, Diabetes, 64, 284, 10.2337/db14-0393 Food Drug Administration. Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers, 2005. 〈https://www.fda.gov/media/72309/download〉. Peng, 2019, Gut microbiota modulation and anti-inflammatory properties of anthocyanins from the fruits of Lycium ruthenicum Murray in dextran sodium sulfate-induced colitis in mice, Free Radic. Biol. Med., 136, 96, 10.1016/j.freeradbiomed.2019.04.005 Cao, 2016, Hypoglycemic activity of the baker's yeast β-glucan in obese/type 2 diabetic mice and the underlying mechanism, Mol. Nutr. Food Res., 60, 2678, 10.1002/mnfr.201600032 Poucher, 2012, Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes, Diabetes Obes. Metab., 14, 918, 10.1111/j.1463-1326.2012.01619.x Luo, 1998, Nongenetic mouse models of non-insulin-dependent diabetes mellitus, Metabolism, 47, 663, 10.1016/S0026-0495(98)90027-0 McKillop, 2016, Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice, Diabetologia, 59, 2674, 10.1007/s00125-016-4108-z Kupriyanova, 2021, Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus, J. Hepatol, 74, 1028, 10.1016/j.jhep.2020.11.030 Teupe, 1991, Epidemiological evidence for "double diabetes", Lancet, 337, 361, 10.1016/0140-6736(91)90988-2 Cleland, 2012, Cardiovascular risk in double diabetes mellitus--when two worlds collide, Nat. Rev. Endocrinol., 8, 476, 10.1038/nrendo.2012.47 Hung, 2017, Protective effects of theasinensin A against carbon tetrachloride-induced liver injury in mice, Food Funct, 8, 3276, 10.1039/C7FO00700K Yamashita, 2012, Fermented tea improves glucose intolerance in mice by enhancing translocation of glucose transporter 4 in skeletal muscle, J. Agric. Food Chem., 60, 11366, 10.1021/jf303597c Qiu, 2012, Transepithelial transport of theasinensins through Caco-2 cell monolayers and their absorption in sprague-dawley rats after oral administration, J. Agric. Food Chem., 60, 8036, 10.1021/jf302242n Lumeng, 2011, Inflammatory links between obesity and metabolic disease, J. Clin. Invest, 121, 2111, 10.1172/JCI57132 Nishimura, 2009, CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity, Nat. Med., 15, 914, 10.1038/nm.1964 Hotamisligil, 1993, Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, J. Am. Med. Assoc., 286, 327, 10.1001/jama.286.3.327 Wang, 2012, Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis, Diabetes Care, 36, 166, 10.2337/dc12-0702 Magkos, 2012, Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects, Gastroenterology, 142, 1444, 10.1053/j.gastro.2012.03.003 Luukkonen, 2016, Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease, J. Hepatol, 64, 1167, 10.1016/j.jhep.2016.01.002 Mauer, 2010, Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance, PLoS Genet, 6, 10.1371/journal.pgen.1000938 Shi, 2006, TLR4 links innate immunity and fatty acid-induced insulin resistance, J. Clin. Invest, 116, 3015, 10.1172/JCI28898 Gupta, 2010, Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway, Hepatology, 51, 1584, 10.1002/hep.23569 Zhou, 2018, Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression, Exp. Mol. Med., 50, 1, 10.1038/s12276-018-0183-1 Saleh, 2021, Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced alzheimer-like pathology model, Sci. Rep., 11, 12040, 10.1038/s41598-021-90545-4 Chadt, 2020, Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease, Pflugers Arch, 472, 1273, 10.1007/s00424-020-02417-x Qiu, 2012, Transepithelial transport of theasinensins through Caco-2 cell monolayers and their absorption in sprague-dawley rats after oral Administration, J. Agric. Food Chem., 60, 8036, 10.1021/jf302242n Que, 2021, Gut bacterial characteristics of patients with type 2 diabetes mellitus and the application potential, Front. Immunol., 12, 3218, 10.3389/fimmu.2021.722206 Knip, 2016, The role of the intestinal microbiota in type 1 diabetes mellitus, Nat. Rev. Endocrinol., 12, 154, 10.1038/nrendo.2015.218 Henning, 2018, Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice, Eur. J. Nutr., 57, 2759, 10.1007/s00394-017-1542-8 Hatano, 2003, Theasinensin A, a tea polyphenol formed from (−)-epigallocatechin gallate, suppresses antibiotic resistance of methicillin-resistant Staphylococcus aureus, Planta Med, 69, 984, 10.1055/s-2003-45142 Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540 Remely, 2017, EGCG prevents high fat diet-induced changes in gut microbiota, decreases of DNA strand breaks, and changes in expression and DNA methylation of dnmt1 and MLH1 in C57BL/6J male mice, Oxid. Med. Cell Longev., 2017, 10.1155/2017/3079148 Lee, 2014, Effect of metformin on metabolic improvement and gut microbiota, Appl. Environ. Microbiol., 80, 5935, 10.1128/AEM.01357-14 Gao, 2018, Effects of qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology, Pharmacol. Res., 130, 93, 10.1016/j.phrs.2018.01.011 Ryan, 2020, Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice, Can. J. Diabetes, 44, 146, 10.1016/j.jcjd.2019.05.008 Lee, 2019, CD1d modulates colonic inflammation in NOD2−/− mice by altering the intestinal microbial composition comprising Acetatifactor muris, J. Crohns Colitis, 13, 1081, 10.1093/ecco-jcc/jjz025 Lagkouvardos, 2016, IMNGS: a comprehensive open resource of processed 16S rRNA microbial profiles for ecology and diversity studies, Sci. Rep., 6, 33721, 10.1038/srep33721 Everard, 2011, Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice, Diabetes, 60, 2775, 10.2337/db11-0227 Liu, 2019, Fuzhuan brick tea attenuates high-fat diet-induced obesity and associated metabolic disorders by shaping gut microbiota, J. Agric. Food Chem, 67, 13589, 10.1021/acs.jafc.9b05833 Natividad, 2018, Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice, Nat. Commun., 9, 1, 10.1038/s41467-018-05249-7 Lam, 2012, Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice, PLoS One, 7, 10.1371/journal.pone.0034233 Tung, 2022, Oolong tea extract alleviates weight gain in high-fat diet-induced obese rats by regulating lipid metabolism and modulating gut microbiota, Food Funct, 13, 2846, 10.1039/D1FO03356E Wang, 2020, Phocea, Pseudoflavonifractor and Lactobacillus intestinalis: three potential biomarkers of gut microbiota that affect progression and complications of obesity-induced type 2 diabetes mellitus, Diabetes Metab. Syndr. Obes., 13, 835, 10.2147/DMSO.S240728 Yassour, 2016, Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes, Genome Med, 8, 1, 10.1186/s13073-016-0271-6 Everard, 2013, Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc. Natl. Acad. Sci. U.S.A, 110, 9066, 10.1073/pnas.1219451110 Plovier, 2017, A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, Nat. Med., 23, 107, 10.1038/nm.4236 Depommier, 2020, Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice, Gut Microbes, 11, 1231, 10.1080/19490976.2020.1737307 Yoon, 2021, Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice, Nat. Microbiol., 6, 563, 10.1038/s41564-021-00880-5 Zheng, 2021, Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice, Microbiome, 9, 1 Perry, 2016, Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome, Nature, 534, 213, 10.1038/nature18309 Freeland, 2010, Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α, Br. J. Nutr., 103, 460, 10.1017/S0007114509991863 Zhao, 2018, Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes, Science, 359, 1151, 10.1126/science.aao5774 Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450 Unno, 2014, Effect of dietary supplementation of (−)-epigallocatechin gallate on gut microbiota and biomarkers of colonic fermentation in rats, J. Nutr. Sci. Vitaminol, 60, 213, 10.3177/jnsv.60.213 Mezhibovsky, 2021, Grape polyphenols attenuate diet-induced obesity and hepatic steatosis in mice in association with reduced butyrate and increased markers of intestinal carbohydrate oxidation, Front. Nutr., 8, 317, 10.3389/fnut.2021.675267 de Goffau, 2013, Fecal microbiota composition differs between children with β-cell autoimmunity and those without, Diabetes, 62, 1238, 10.2337/db12-0526